1347581-78-5

Basic information

• Product Name: 5-[1-(3-Bromobenzyl)-5-methyl-1H-pyrazol-3-yl]-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole
• Synonyms: 5-[1-(3-Bromobenzyl)-5-methyl-1H-pyrazol-3-yl]-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole
• CAS NO: 1347581-78-5
• Molecular Weight: 495.323
• Mol File: 1347581-78-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-[1-(3-Bromobenzyl)-5-methyl-1H-pyrazol-3-yl]-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[1-(3-Bromobenzyl)-5-methyl-1H-pyrazol-3-yl]-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole(1347581-78-5)
• EPA Substance Registry System: 5-[1-(3-Bromobenzyl)-5-methyl-1H-pyrazol-3-yl]-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole(1347581-78-5)

Safety Data

• Hazardous Substances Data: 1347581-78-5(Hazardous Substances Data)

Upstream product

• 823-78-9 meta-bromobenzyl bromide 
• 1346690-03-6 5-(5-Methyl-1H-pyrazol-3-yl)-3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazole 
• 1085453-81-1 N'-hydroxy-4-[(trifluoromethyl)sulphanyl]benzenecarboximidamide 
• 332-26-3 4-[(trifluoromethyl)sulphanyl]benzenecarbonitrile 

Downstream Products

• 1347581-55-8 1-(3-{[5-Methyl-3-(3-{4-[(trifluoromethyl)sulphanyl]phenyl}-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl]methyl}phenyl)piperidin-4-ol 

Relevant articles and documents

Substituted heterocyclylbenzylpyrazoles and use thereof

The present application relates to novel substituted 1-[3-(heterocyclyl)benzyl]-1H-pyrazole derivatives, to processes for preparation thereof, to use thereof for treatment and/or prevention of diseases and to use thereof for production of medicaments for treatment and/or prevention of diseases, more particularly for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be effected in the form of monotherapy or else in combination with other medicaments or further therapeutic measures.